EUVIMEDEUVIMED entdecken
Crossref

Trends of Authors' Conflicts of Interest in Clinical Trials Published in the Journal of Clinical Oncology : A Large Language Model–Assisted Longitudinal Study

Jiasheng Wang iD, Pedro C Silberman iD, Sayan Mullick Chowdhury, Bradley W Blaser iD

JCO Oncology Practice · 2025

DOI: 10.1200/op-25-00293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Jiasheng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Conflict of Interest, Medical Oncology, Authorship. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Conflicts of interest (COIs) between clinical trial investigators and biopharmaceutical companies have raised concerns about potential bias in research. This study aimed to systematically analyze the prevalence and trends of COIs in oncology clinical trials published in the Journal of Clinical Oncology (JCO) for the past 15 years and to demonstrate the utility of large language models (LLMs) for automated data extraction in this context. METHODS We identified clinical trials published in the JCO from 2010 to 2025 using PubMed. We extracted publication data and author disclosures from the JCO Web site. OpenAI's GPT-4o was used to identify the main medical product studied and the related biopharmaceutical company and their variants in author disclosures. We then analyzed COI trends across three time periods (2010-2015, 2015-2020, 2020-2025). RESULTS GPT-4o demonstrated close to 95% accuracy in identifying medical products and companies. Of the 2,583 clinical trials, 2,219 (85.9%) involved a medical product. Among these, 1,610 (72.6%) had at least one author with a COI related to the associated biopharmaceutical company. COI prevalence increased from 70.0% (2010-2015) to 77.0% (2015-2020), and then decreased to 72.0% (2020-2025). Company employment, advisory roles, and honoraria were common COI types and followed similar trends. US-led studies had a significantly higher COI prevalence than those from other regions (77.6% v 67.3%; P < .001). Additionally, 61.9% of first or last authors had a COI, which increased consistently over three time periods. CONCLUSION This study reveals widespread COIs in oncology clinical trials, particularly in US-led studies and among leading authors, with discernible temporal patterns. The LLM-based method provides an efficient solution for COI monitoring, promoting transparency in biomedical research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicConflict of InterestMedical OncologyAuthorshipHumansLongitudinal StudiesLarge Language Models

Autor:innen und Institutionen

  • Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • College of Medicine, The Ohio State University, Columbus, OH.
  • Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH.

ORCID-Profile: Jiasheng Wang, Pedro C Silberman, Bradley W Blaser

Zitieren

APA

Wang, J., Silberman, P. C., Mullick Chowdhury, S., & Blaser, B. W. (2025). Trends of Authors' Conflicts of Interest in Clinical Trials Published in the Journal of Clinical Oncology : A Large Language Model–Assisted Longitudinal Study. JCO Oncology Practice. https://doi.org/10.1200/op-25-00293

Vancouver

Wang J, Silberman PC, Mullick Chowdhury S, Blaser BW. Trends of Authors' Conflicts of Interest in Clinical Trials Published in the Journal of Clinical Oncology : A Large Language Model–Assisted Longitudinal Study. JCO Oncology Practice. 2025. doi:10.1200/op-25-00293

BibTeX
@article{Wang2025,
  author = {Wang, Jiasheng and Silberman, Pedro C and Mullick Chowdhury, Sayan and Blaser, Bradley W},
  title = {Trends of Authors' Conflicts of Interest in Clinical Trials Published in the Journal of Clinical Oncology : A Large Language Model–Assisted Longitudinal Study},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-25-00293}
}
Kostenlos starten →